These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27379095)

  • 1. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
    Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ
    Front Immunol; 2016; 7():232. PubMed ID: 27379095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
    Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
    J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
    Ebert S; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):541-50. PubMed ID: 22976556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
    Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():694588. PubMed ID: 34489940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation.
    Reddehase MJ
    Front Immunol; 2016; 7():294. PubMed ID: 27540380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
    Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
    Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.
    Holtappels R; Büttner JK; Freitag K; Reddehase MJ; Lemmermann NA
    Front Immunol; 2024; 15():1355153. PubMed ID: 38426094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.
    Holtappels R; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ
    Med Microbiol Immunol; 2015 Jun; 204(3):317-26. PubMed ID: 25805564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.
    Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW
    Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
    Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
    J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells.
    Freitag K; Hamdan S; Reddehase MJ; Holtappels R
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
    Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ
    PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
    Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
    Reddehase MJ; Lemmermann NAW
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.
    Hamdan S; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2023 Apr; 212(2):153-163. PubMed ID: 35364731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
    Holtappels R; Podlech J; Freitag K; Lemmermann NA; Reddehase MJ
    Viruses; 2022 May; 14(6):. PubMed ID: 35746617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
    Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection.
    Podlech J; Ebert S; Becker M; Reddehase MJ; Stassen M; Lemmermann NA
    Med Microbiol Immunol; 2015 Jun; 204(3):327-34. PubMed ID: 25648117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.